Evidence map›Paper›PMID 23378214›Full record

ArticleCell stress & chaperones2013

ERK signaling is triggered by hepatitis C virus E2 protein through DC-SIGN.

Lan-Juan Zhao, Wen Wang, Hao Ren, Zhong-Tian Qi

Abstract read
In one paragraph

Article in Cell stress & chaperones, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Antiviral activity of berberine.Archives of virology · 2020
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lan-Juan ZhaoDepartment of Microbiology, Shanghai Key Laboratory of Medical Biodefense, Second Military Medical University, Shanghai, People's Republic of China.
Wen Wang
Hao Ren
Zhong-Tian Qi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) is a binding receptor for hepatitis C virus (HCV). Binding of HCV envelope protein E2 to target cells is a prerequisite to DC-SIGN-mediated signaling. Using cell lines with stable or transient expression of DC-SIGN, we investigated effects of soluble HCV E2 protein on ERK pathway. MEK and ERK are activated by the E2 in NIH3T3 cells stably expressing DC-SIGN. Treatment of the cells with antibody to DC-SIGN results in inhibition of the E2 binding as well as the E2-induced MEK and ERK activation. In HEK293T cells transiently expressing DC-SIGN, activation of MEK and ERK is also induced by the E2. Activation of ERK pathway by HCV E2 through DC-SIGN provides useful information for understanding cellular receptor-mediated signaling.

Indexed as

AnimalsAntibodiesCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinExtracellular Signal-Regulated MAP KinasesHEK293 CellsHepacivirusHumansLectins, C-TypeMAP Kinase Kinase KinasesMAP Kinase Signaling SystemMiceNIH 3T3 CellsProtein BindingReceptors, Cell SurfaceTransfectionAntibodiesCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinExtracellular Signal-Regulated MAP Kinasesglycoprotein E2, Hepatitis C virusLectins, C-TypeMAP Kinase Kinase KinasesReceptors, Cell SurfaceViral Envelope Proteins

Identifiers

PMID23378214
PMCPMC3682013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.